Drug Pipeline

Favipiravir Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
5
Recruiting
1
Phase 3
4
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-02 NCT04746183
AGILE (Early Phase Platform Trial for COVID-19)		 date change Primary completion pushed: 2026-07-31 -> 2027-03-31
2026-06-02 NCT04746183
AGILE (Early Phase Platform Trial for COVID-19)		 date change Completion pushed: 2026-07-31 -> 2027-03-31
Active Studies by Phase
Phase 2/3
1
Phase 2
2
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT06212336 ISTH/ANRS 0409s INTEGRATE Lassa Fever Study Lassa Fever Recruiting
Phase 2
NCT05041907 Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early… COVID-19 Recruiting
NCT05648448 A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza Influenza Recruiting
Phase 1/2
NCT04746183 AGILE (Early Phase Platform Trial for COVID-19) Covid19 Recruiting
Phase 1
NCT06024421 Evaluation of Tolerance and Pharmacokinetic Profile of High Doses of Favipiravir in… Infectious Disease Recruiting
Sponsors Running Favipiravir Trials
University of Oxford (2) University of Liverpool (1) Institut National de la Santé Et de la Recherche Médicale, France (1) Irrua Specialist Teaching Hospital (1)
Get alerts when Favipiravir trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free